TGFB1 and neoplasm: Thus, by inhibiting both the VEGF and TGF‐β/Smad signaling pathways, miR‐190 has the potential to reduce VEGF expression and angiogenesis, increase tumor sensitivity to anticancer drugs, and reduce chemoresistance, respectively.106